Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

We continue to work closely with our partner to enable a seamless ... immunologic comparisons to establish non-inferiority ...

China has reported seven more H9N2 avian flu infections in humans, mostly involving children and all in people whose symptoms ...

The candidate vaccines are part of Novavax's portfolio of recombinant protein-based vaccines ... the ID-UTI measure can be ...

MD and senior director of medical affairs in Europe for Novavax, who has worked in vaccines for 20 years or so, explained that protein-based vaccines work, very simply, by protecting humans by ...

Novavax, Inc., based in Gaithersburg, Maryland, is a global biotechnology company focused on developing and commercializing innovative protein-based vaccines to combat serious infectious diseases, ...

In a report released today, Brendan Smith from TD Cowen maintained a Hold rating on Novavax (NVAX – Research Report), with a price target ...

Novavax has received the green light from the US Food and Drug Administration (FDA) to resume clinical trials for its ...

Inovio Pharmaceuticals Inc. 0.36% $143.32M ...